Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)

NCT03932136 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Clinical High Risk Syndrome of Psychosis

Interventions

DIETARY_SUPPLEMENT: Sulforaphane
COMBINATION_PRODUCT: Placebo

Sponsor

Shanghai Jiao Tong University School of Medicine

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]